Unique Pharmaceutical Laboratories Recalls Cetirizine Hydrochloride Due to Ranitidine Contamination
Unique Pharmaceutical Laboratories is recalling four lots of Cetirizine Hydrochloride Tablets due to cross contamination with Ranitidine.
Company
Unique Pharmaceutical Laboratories
Signal assessment
Signal strength
high
Confidence level
high
Why it matters
The recall of Cetirizine Hydrochloride due to contamination with Ranitidine raises significant safety concerns that could undermine consumer trust in antihistamine products. This incident may prompt regulatory scrutiny and necessitate a reassessment of safety protocols across the sector.
Recommended action
Humanexa recommends Investigate.
Analysis
Monitor for further recalls or safety alerts related to antihistamines and any regulatory responses.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.